-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Calidi Biotherapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q3 2022 to Q2 2024.
- Calidi Biotherapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $100K, unchanged year-over-year.
- Calidi Biotherapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $401K.
- Calidi Biotherapeutics, Inc. annual Depreciation for 2023 was $392K, a 50.8% increase from 2022.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)